[SLN] QoQ Quarter Result on 30-Sep-2022 [#Q3]

Stock
[SLN] Silence Therapeutics plc
Announcement Date
29-Sep-2022
Financial Year
2022
Quarter
30-Sep-2022 [#Q3]
Profit Trend
QoQ- 40.51%
YoY- 28.46%
Quarter Report
SLN's Result
SLN's Financial Summary
View:
Show?
Quarter Result
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
Revenue 9,104 11,374 4,765 3,371 3,643 5,722 3,414 92.64%
PBT -12,010 -12,673 -15,050 -9,326 -13,420 -9,572 -11,227 4.60%
Tax -1,609 -2,469 -1,287 -2,223 -1,481 -1,888 -1,793 -6.98%
NP -10,401 -10,204 -13,763 -7,103 -11,939 -7,684 -9,434 6.74%
Tax Rate - - - - - - - -
Total Cost 19,505 21,578 18,528 10,474 15,582 13,406 12,848 32.19%
Ratio Analysis
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
NP Margin -114.25 -89.71 -288.84 -210.71 -327.72 -134.29 -276.33 -44.59%
Per Share
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
EPS -0.29 -0.28 -0.43 -0.22 -0.40 -0.26 -0.32 -6.36%
EPS Diluted -0.29 -0.28 -0.43 -0.22 -0.40 -0.26 -0.32 -6.36%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.